Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if MANE is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
32 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 54 days ago
Red flags: 2
164 filers reported a long position in MANE for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $512.5M | 4.2M | Unchanged |
| FMR LLC | $394M | 3.2M | +78.8% |
| SR ONE CAPITAL MANAGEMENT, LP | $295.3M | 2.4M | Unchanged |
| Deep Track Capital, LP | $245.9M | 2M | +300% |
| CITADEL ADVISORS LLC | $230.9M | 1.9M | +2.9% |
| Siren, L.L.C. | $203.5M | 1.7M | +10% |
| BlackRock, Inc. | $195.9M | 1.6M | +464% |
| VIKING GLOBAL INVESTORS LP | $192M | 1.6M | -7.6% |
| JPMORGAN CHASE & CO | $144.2M | 1.2M | +19.4% |
| Aberdeen Group plc | $134.8M | 1.1M | +4% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.